BackRapid Dose Therapeutics Overview

Rapid Dose Therapeutics Receivables

Track Rapid Dose Therapeutics's receivables ($120K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$118772.00
↓ 40.82% YoYΔ $-81938.00 vs prior year quarter

Peer trimmed avg / median

Loading

Rapid Dose Therapeutics Receivables History

Loading

Rapid Dose Therapeutics vs. peers: Receivables Comparison

Loading

Rapid Dose Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rapid Dose Therapeutics (DOSE.CN) FAQ

Rapid Dose Therapeutics (DOSE.CN) currently reports a receivables of $120K as of May 2026. That compares with $200K in the prior-year period — down 40.8% year over year. Use the charts on this page to explore Rapid Dose Therapeutics's receivables history and peer comparisons.

Rapid Dose Therapeutics's receivables decreased from $200K to $120K — a 40.8% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rapid Dose Therapeutics reported $120K in receivables as of May 2026. That compares with $200K in the prior-year period — down 40.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $120K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rapid Dose Therapeutics, and consider following DOSE.CN for alerts when major investors trade the stock.

Rapid Dose Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $120K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DOSE.CN with unrelated industries.